AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
For the third year in a row, the hundreds of millions of dollars poured into commercials for AbbVie ... according to iSpot.TV, while Dupixent's total was about $100 million lower than Skyrizi ...
Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...
Vicks retained the top monthly spot for TV ad impressions among Rx and over-the-counter (OTC) pharma brands, according to data released by iSpot.tv on Wednesday afternoon ... Sanofi and Regeneron’s ...
Dupixent (dupilumab) is a brand-name injection that’s prescribed for treating asthma. This article covers topics such as side effects, dosage, and how Dupixent works. Dupixent is available as a ...
Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...
One primary reason is the strong performance and potential of Dupixent, which is expected to partially counterbalance the uncertainties surrounding Eylea. The expected growth in Dupixent’s ...
Millions of Americans will tune into the 2025 Super Bowl on Sunday not only to watch the championship game, but also to check out the big-budget commercials from some of the nation's biggest ...
Not only are people excited to watch the football game and cheer on their favorite team, they are eager to see the commercials too. An Ipsos survey conducted in December found that nearly 80% of ...
Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone ...
The new 60-second ad turns up in Super Bowl LIX alongside commercials for parent company Anheuser-Busch InBev’s Stella Artois, Budweiser and Michelob Ultra. The characters would seem to be the ...
Real estate-services firm CBRE Group is taking control of the co-working firm Industrious, a sign of the property market’s renewed interest in shared workspace as more employees return to the ...